肠道菌群及短链脂肪酸与慢性自发性荨麻疹相关性研究进展

doi:10.35541/cjd.20230310

Abstract

Abstract: 【Abstract】 Autoimmunity and the activation of immune cells are closely related to the occurrence of chronic spontaneous urticaria. while the gut microbiota participates in multiple physiological activities including the regulation of the host′s immunity. Gut microbiota in patients with chronic spontaneous urticaria has unique structural composition and metabolic features. Gut microbiota imbalance and secondary short-chain fatty acid deficiency may be important causes for the occurrence of the disease and aggravation of inflammation. Studies have shown that probiotics can improve the clinical manifestations of patients with urticaria. This review summarizes the research progress in the correlations of gut microbiota and short-chain fatty acids with chronic spontaneous urticaria.

Key words: Urticaria, Chronic spontaneous urticaria, Gut microbiota, Short-chain fatty acids

Enze LI Lu CHEN Chu-Qiao ZHANG Jiao qingqing JI Jiang. Correlations of gut microbiota and short-chain fatty acids with chronic spontaneous urticaria[J]. Chinese Journal of Dermatology,2024,e20230310. doi:10.35541/cjd.20230310

References ［41］

［1］	Bansal CJ, Bansal AS. Stress, pseudoallergens, autoimmunity, infection and inflammation in chronic spontaneous urticaria［J］. Allergy Asthma Clin Immunol, 2019,15:56. doi: 10.1186/s13223⁃019⁃0372⁃z.
［2］	MacGlashan D. Autoantibodies to IgE and FcεRI and the natural variability of spleen tyrosine kinase expression in basophils［J］. J Allergy Clin Immunol, 2019,143（3）:1100⁃1107.e11. doi: 10. 1016/j.jaci.2018.05.019.
［3］	Jiao Y, Wu L, Huntington ND, et al. Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases［J］. Front Immunol, 2020,11:282. doi: 10.3389/fimmu.2020.00282.
［4］	Jethwani P, Grover K. Gut microbiota in health and diseases ⁃ a review［J］. Int J Curr Microbiol Appl Sci, 2019,8:1586⁃1599. doi: 10.20546/ijcmas.2019.808.187.
［5］	Bunyavanich S, Shen N, Grishin A, et al. Early⁃life gut microbiome composition and milk allergy resolution［J］. J Allergy Clin Immunol, 2016,138（4）:1122⁃1130. doi: 10.1016/j.jaci.2016.03.041.
［6］	Zhang X, Chen BD, Zhao LD, et al. The gut microbiota: emerging evidence in autoimmune diseases［J］. Trends Mol Med, 2020,26（9）:862⁃873. doi: 10.1016/j.molmed.2020.04.001.
［7］	McDermott AJ, Huffnagle GB. The microbiome and regulation of mucosal immunity［J］. Immunology, 2014,142（1）:24⁃31. doi: 10.1111/imm.12231.
［8］	Hooper LV. Bacterial contributions to mammalian gut develop⁃ment［J］. Trends Microbiol, 2004,12（3）:129⁃134. doi: 10.1016/j.tim.2004.01.001.
［9］	Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota［J］. Environ Microbiol, 2017,19（1）:29⁃41. doi: 10.1111/1462⁃2920.13589.
［10］	Singh RK, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and implications for human health［J］. J Transl Med, 2017,15（1）:73. doi: 10.1186/s12967⁃017⁃1175⁃y.
［11］	Nabizadeh E, Jazani NH, Bagheri M, et al. Association of altered gut microbiota composition with chronic urticaria［J］. Ann Allergy Asthma Immunol, 2017,119（1）:48⁃53. doi: 10.1016/j.anai.2017.05.006.
［12］	Rezazadeh A, Shahabi S, Bagheri M, et al. The protective effect of Lactobacillus and Bifidobacterium as the gut microbiota members against chronic urticaria［J］. Int Immunopharmacol, 2018,59:168⁃173. doi: 10.1016/j.intimp.2018.04.007.
［13］	Lu T, Chen Y, Guo Y, et al. Altered gut microbiota diversity and composition in chronic urticaria［J］. Dis Markers, 2019,2019:6417471. doi: 10.1155/2019/6417471.
［14］	Zhang X, Zhang J, Chu Z, et al. Gut Microbiome alterations and functional prediction in chronic spontaneous urticaria patients［J］. J Microbiol Biotechnol, 2021,31（5）:747⁃755. doi: 10.4014/jmb.2012.12022.
［15］	Wang D, Guo S, He H, et al. Gut microbiome and serum metabolome analyses identify unsaturated fatty acids and butanoate metabolism induced by gut microbiota in patients with chronic spontaneous urticaria［J］. Front Cell Infect Microbiol, 2020,10:24. doi: 10.3389/fcimb.2020.00024.
［16］	Yüksekal G, Sevimli Dikicier B, Koku Aydın B, et al. Investigation of intestinal microbiome in chronic spontaneous urticaria patients［J］. Int J Dermatol, 2022,61（8）:988⁃994. doi: 10.1111/ijd.16054.
［17］	Shi YZ, Tao QF, Qin HY, et al. Causal relationship between gut microbiota and urticaria: a bidirectional two⁃sample mendelian randomization study［J］. Front Microbiol, 2023,14:1189484. doi: 10.3389/fmicb.2023.1189484.
［18］	Ćesić D, Lugović Mihić L, Ozretić P, et al. Association of gut lachnospiraceae and chronic spontaneous urticaria［J］. Life （Basel）, 2023,13（6）:1280. doi: 10.3390/life13061280.
［19］	Vacca M, Celano G, Calabrese FM, et al. The controversial role of human gut lachnospiraceae［J］. Microorganisms, 2020,8（4）:573. doi: 10.3390/microorganisms8040573.
［20］	Su YJ, Luo SD, Hsu CY, et al. Differences in gut microbiota between allergic rhinitis, atopic dermatitis, and skin urticaria: a pilot study［J］. Medicine （Baltimore）, 2021,100（9）:e25091. doi: 10.1097/MD.0000000000025091.
［21］	Song Y, Dan K, Yao Z, et al. Altered gut microbiota in H1⁃antihistamine⁃resistant chronic spontaneous urticaria associates with systemic inflammation［J］. Front Cell Infect Microbiol, 2022,12:831489. doi: 10.3389/fcimb.2022.831489.
［22］	Wang X, Yi W, He L, et al. Abnormalities in gut microbiota and metabolism in patients with chronic spontaneous urticaria［J］. Front Immunol, 2021,12:691304. doi: 10.3389/fimmu.2021. 691304.
［23］	Luo Z, Jin Z, Tao X, et al. Combined microbiome and metabolome analysis of gut microbiota and metabolite interactions in chronic spontaneous urticaria［J］. Front Cell Infect Microbiol, 2022,12:1094737. doi: 10.3389/fcimb.2022.1094737.
［24］	Pérez⁃Pérez S, Domínguez⁃Mozo MI, Alonso⁃Gómez A, et al. Acetate correlates with disability and immune response in multiple sclerosis［J］. PeerJ, 2020,8:e10220. doi: 10.7717/peerj.10220.
［25］	Li P, Jiang M, Li K, et al. Glutathione peroxidase 4⁃regulated neutrophil ferroptosis induces systemic autoimmunity［J］. Nat Immunol, 2021,22（9）:1107⁃1117. doi: 10.1038/s41590⁃021⁃00993⁃3.
［26］	任媛, 张敏, 殷翔, 等. 肠道菌群对慢性荨麻疹患者血清炎症因子的影响［J］. 检验医学, 2021,36（5）:504⁃509. doi: 10.3969/j.issn.1673⁃8640.2021.05.009.
［27］	Yao Y, Cai X, Fei W, et al. The role of short⁃chain fatty acids in immunity, inflammation and metabolism［J］. Crit Rev Food Sci Nutr, 2022,62（1）:1⁃12. doi: 10.1080/10408398.2020.1854675.
［28］	Haase S, Mäurer J, Duscha A, et al. Propionic acid rescues high⁃fat diet enhanced immunopathology in autoimmunity via effects on Th17 responses［J］. Front Immunol, 2021,12:701626. doi: 10.3389/fimmu.2021.701626.
［29］	Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe⁃derived butyrate induces the differentiation of colonic regulatory T cells［J］. Nature, 2013,504（7480）:446⁃450. doi: 10.1038/nature12721.
［30］	Folkerts J, Redegeld F, Folkerts G, et al. Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI⁃mediated signaling［J］. Allergy, 2020,75（8）:1966⁃1978. doi: 10.1111/all. 14254.
［31］	Krejner A, Bruhs A, Mrowietz U, et al. Decreased expression of G⁃protein⁃coupled receptors GPR43 and GPR109a in psoriatic skin can be restored by topical application of sodium butyrate［J］. Arch Dermatol Res, 2018,310（9）:751⁃758. doi: 10.1007/s00403⁃018⁃1865⁃1.
［32］	Schlatterer K, Peschel A, Kretschmer D. Short⁃chain fatty acid and FFAR2 activation ⁃ a new option for treating infections?［J］. Front Cell Infect Microbiol, 2021,11:785833. doi: 10.3389/fcimb.2021.785833.
［33］	Kang J, Im DS. FFA2 activation ameliorates 2,4⁃dinitrochlorobenzene⁃induced atopic dermatitis in mice［J］. Biomol Ther （Seoul）, 2020,28（3）:267⁃271. doi: 10.4062/biomolther.2019.160.
［34］	Zhang H, Du M, Yang Q, et al. Butyrate suppresses murine mast cell proliferation and cytokine production through inhibiting histone deacetylase［J］. J Nutr Biochem, 2016,27:299⁃306. doi: 10.1016/j.jnutbio.2015.09.020.
［35］	Shi Y, Xu M, Pan S, et al. Induction of the apoptosis, degranulation and IL⁃13 production of human basophils by butyrate and propionate via suppression of histone deacetylation［J］. Immunology, 2021,164（2）:292⁃304. doi: 10.1111/imm. 13370.
［36］	Nettis E, Di Leo E, Pastore A, et al. Probiotics and refractory chronic spontaneous urticaria［J］. Eur Ann Allergy Clin Immunol, 2016,48（5）:182⁃187.
［37］	Bi XD, Lu BZ, Pan XX, et al. Adjunct therapy with probiotics for chronic urticaria in children: randomised placebo⁃controlled trial［J］. Allergy Asthma Clin Immunol, 2021,17（1）:39. doi: 10.1186/ s13223⁃021⁃00544⁃3.
［38］	Atefi N, Fallahpour M, Sharifi S, et al. Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled clinical trial［J］. Eur Ann Allergy Clin Immunol, 2022,54（3）:123⁃130. doi: 10.23822/EurAnnACI.1764⁃1489.200.
［39］	Furci F, Caminati M, Crisafulli E, et al. The intriguing possibility of using probiotics in allergen⁃specific immunotherapy［J］. World Allergy Organ J, 2023,16（2）:100751. doi: 10.1016/j.waojou.2023.100751.
［40］	Schwarz A, Bruhs A, Schwarz T. The short⁃chain fatty acid sodium butyrate functions as a regulator of the skin immune system［J］. J Invest Dermatol, 2017,137（4）:855⁃864. doi: 10. 1016/j.jid.2016.11.014.
［41］	Schwarz A, Philippsen R, Schwarz T. Induction of regulatory T cells and correction of cytokine disbalance by short⁃chain fatty acids: implications for psoriasis therapy［J］. J Invest Dermatol, 2021,141（1）:95⁃104.e2. doi: 10.1016/j.jid.2020.04.031.

[1]	Yue Shuzhen, Shu Ye, Luo Yangyang, Li Keyao, Zhang Yuanyuan, Tang Jianping, Wei Zhu. Efficacy and safety of omalizumab in the treatment of chronic urticaria in children: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(4): 354-358.
[2]	Zhou Tiantian, Wu Xuege, Yang Huan, Fang Xiao, Jiang Jinqiu, Chen Jingsi, Luo Xiaoyan, Wang Hua. Analysis of the etiology and factors associated with the severity of chronic spontaneous urticaria in children [J]. Chinese Journal of Dermatology, 2024, 57(4): 324-330.
[3]	Li Yuanjun, Han Yuyang, Zhang Huanzhen, Wang Hui, Shen Nan, Zhang Xinglian. Dupilumab in the treatment of 12 children with chronic spontaneous urticaria: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(3): 254-257.
[4]	Li Chunying, Chen Jianru, Li Shuli. Metabolic reconfiguration in vitiligo: progress and future [J]. Chinese Journal of Dermatology, 2024, 57(1): 8-11.
[5]	Jiao Qingqing, Zhang Xiaoyan, Ji Jiang. Biological indicators related to disease activity of chronic spontaneous urticaria: an update [J]. Chinese Journal of Dermatology, 2023, 56(6): 559-562.
[6]	Chen Qiquan, Yang Xianjie, Wang Wenwen, Liang Gaopeng, Song Zhiqiang . Development and application of clinical assessment tools for cholinergic urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 563-566.
[7]	Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023）” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539.
[8]	Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023） [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488.
[9]	Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on treat-to-target in chronic spontaneous urticaria （2023） [J]. Chinese Journal of Dermatology, 2023, 56(6): 489-495.
[10]	Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558.
[11]	Zhang Liming, Xiao Ting. Update of the autoimmune pathogenesis of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 567-570.
[12]	Yang Nali, Xu Qiuyang, Wu Hanwen, Ye Yahui, Zhu Jiling, Liu Jingjing, Li Zhiming. Efficacy and safety of omalizumab in the treatment of chronic urticaria: a retrospective analysis [J]. Chinese Journal of Dermatology, 2023, 56(6): 518-524.
[13]	Chen Qiquan, Kong Minmin, Yang Xianjie, Wang Huan, Li Jian, Zhang Mingwang, Song Zhiqiang. Clinical analysis of allergen reactivity and atopic disease history in 168 patients with chronic inducible urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 496-503.
[14]	Su Chang, Sui Xiuli, Liu Ruiling, Cao Yiqun, Jiang Hong, Yan Cairong, Wang Huiping, Qi Yuqing. Omalizumab for the treatment of 74 patients with chronic spontaneous urticaria accompanied by other allergic diseases: a clinical analysis [J]. Chinese Journal of Dermatology, 2023, 56(6): 512-517.
[15]	Wang Xin, Liu Lijuan, Li Linfeng. Clinical features of chronic spontaneous urticaria in China: results from a hospital-based multicenter epidemiological survey [J]. Chinese Journal of Dermatology, 2023, 56(6): 525-530.

Correlations of gut microbiota and short-chain fatty acids with chronic spontaneous urticaria

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［41］

Related Articles 15

Metrics

Comments

Recommended 10